Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127723551 | 12772355 | 1 | I | 201509 | 20160913 | 20160922 | 20160922 | EXP | GB-MHRA-ADR 23634312 | GB-MYLANLABS-2016M1039418 | MYLAN | 0.00 | Y | 0.00000 | 20160922 | MD | GB | GB |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127723551 | 12772355 | 1 | PS | LANSOPRAZOLE. | LANSOPRAZOLE | 1 | 15 MG, QD | Y | U | 90763 | 15 | MG | QD | ||||||
| 127723551 | 12772355 | 2 | SS | LANSOPRAZOLE. | LANSOPRAZOLE | 1 | 30 MG, BID | Y | U | 90763 | 30 | MG | BID | ||||||
| 127723551 | 12772355 | 3 | C | PARACETAMOL | ACETAMINOPHEN | 1 | 500 MG, UNK | U | 0 | 500 | MG | ||||||||
| 127723551 | 12772355 | 4 | C | ATORVASTATIN | ATORVASTATIN | 1 | 20 MG, QD | U | 0 | 20 | MG | QD | |||||||
| 127723551 | 12772355 | 5 | C | HALOPERIDOL. | HALOPERIDOL | 1 | 0.5 MG, UNK | U | 0 | .5 | MG | ||||||||
| 127723551 | 12772355 | 6 | C | NAPROXEN. | NAPROXEN | 1 | 250 MG, BID (LONG TERM) | U | 0 | 250 | MG | BID | |||||||
| 127723551 | 12772355 | 7 | C | LOPRAZOLAM | LOPRAZOLAM | 1 | 1 MG, UNK (HALF A TABLET AT NIGHT.) | U | 0 | 1 | MG | TABLET | |||||||
| 127723551 | 12772355 | 8 | C | COLCHICINE. | COLCHICINE | 1 | 500 ?G, UNK | U | 0 | 500 | UG | ||||||||
| 127723551 | 12772355 | 9 | C | RANITIDINE. | RANITIDINE | 1 | 150 MG, BID | U | 0 | 150 | MG | BID | |||||||
| 127723551 | 12772355 | 10 | C | ALLOPURINOL. | ALLOPURINOL | 1 | 300 MG, QD (AT NIGHT.) | U | 0 | 300 | MG | QD | |||||||
| 127723551 | 12772355 | 11 | C | QUININE SULPHATE | QUININE SULFATE | 1 | 200 MG, QD (AT NIGHT.) | U | 0 | 200 | MG | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127723551 | 12772355 | 1 | Prophylaxis against gastrointestinal ulcer |
| 127723551 | 12772355 | 6 | Osteoarthritis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127723551 | 12772355 | DS |
| 127723551 | 12772355 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127723551 | 12772355 | Abnormal faeces | |
| 127723551 | 12772355 | Abnormal loss of weight | |
| 127723551 | 12772355 | Change of bowel habit | |
| 127723551 | 12772355 | Decreased appetite | |
| 127723551 | 12772355 | Diarrhoea | |
| 127723551 | 12772355 | Diverticulum | |
| 127723551 | 12772355 | Dizziness | |
| 127723551 | 12772355 | Dry mouth | |
| 127723551 | 12772355 | Fatigue | |
| 127723551 | 12772355 | Flatulence | |
| 127723551 | 12772355 | Gastritis | |
| 127723551 | 12772355 | Haemoglobin decreased | |
| 127723551 | 12772355 | Liver function test abnormal | |
| 127723551 | 12772355 | Nausea | |
| 127723551 | 12772355 | Pruritus | |
| 127723551 | 12772355 | Skin haemorrhage | |
| 127723551 | 12772355 | Vomiting |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127723551 | 12772355 | 1 | 201508 | 201510 | 0 | |
| 127723551 | 12772355 | 2 | 201510 | 201607 | 0 |